Press release
Global Fentanyl Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
The Fentanyl Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].What Is the Fentanyl Market Size and Projected Growth Rate?
In the past few years, the fentanyl market has seen robust growth. It is projected to expand from $16.22 billion in 2024 to $17.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%. Elements such as increased demand for pain management, medical procedures and surgeries, cancer pain control, growth in the opioid analgesic market, and an aging demographic have contributed to growth during the historic period.
In the coming years, the fentanyl market size is anticipated to undergo robust growth. The market is projected to expand to $22.31 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period can be associated with an increase in chronic pain cases, development in oncology treatments, a rise in surgical procedures, public health drives, and regulatory sanction for new usages. Key trends for this forecast period encompass advancements in drug formulation technology, technological breakthroughs in detection, strategies for public health and harm reduction, an increase in pharmaceutical applications, as well as international cooperation and information exchange.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237
What Are the Major Segments in the Fentanyl Market?
The fentanyl market covered in this report is segmented -
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations
2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp
What Are The Driving Fentanyl Market Evolution?
The fentanyl market is anticipated to expand due to the rising stats of chronic illnesses. Chronic illnesses are long-term medical conditions, often persisting for three months or longer, and in many cases, an individual experiences them for the entirety of their life. Fentanyl is primarily utilized to manage intense, continuous pain resulting from chronic diseases, which can't be effectively mitigated by other medications or interventions. For example, the Centers for Disease Control and Prevention (CDC), a public health agency in the United States, reported in the Heart Disease Facts in October 2024 that coronary heart disease (CHD) caused 371,506 deaths out of 702,880 total heart disease-related fatalities in 2022 in the United States. Hence, the escalating occurrence of chronic diseases is fueling the fentanyl market's growth. Fentanyl Market Driver: Increased Need For Pain Management Fuels Fentanyl Market's Advancement
Which Firms Dominate The Fentanyl Market Segments?
Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.
What Trends Are Expected to Dominate the Fentanyl Market in the Next 5 Years?
Key players in the fentanyl market are pioneering new products like Opvee and securing permissions to reach a larger clientele, boost sales, and augment their revenue. Opvee (nalmefene) is a robust antagonist of opioid receptors used to counteract confirmed or potential opioid overdose caused by organic or synthetic opioids such as fentanyl. For example, Indivior PLC, a pharmaceutical firm based in the US, gained the approval of the U.S. Food and Drug Administration for Opvee's nasal spray in May 2023. This product works by blocking the impact of opioids on the brain, aiding patients who have recently overdosed by restoring their respiration and blood pressure levels. The ease of administering Opvee as a nasal spray makes it particularly handy during emergencies. It forms a vital part of the arsenal of medicines used to tackle opioid overdoses and save human lives.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report
Which Is The Largest Region In The Fentanyl Market?
North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Fentanyl Market?
2. What is the CAGR expected in the Fentanyl Market?
3. What Are the Key Innovations Transforming the Fentanyl Industry?
4. Which Region Is Leading the Fentanyl Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Fentanyl Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here
News-ID: 4024714 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Fentanyl
Segmentation, Major Trends, and Competitive Overview of the Fentanyl Market
The fentanyl market is set to experience considerable growth in the coming years, driven by increasing medical needs and advancements in pharmaceutical technology. Understanding the factors behind this expansion, the key players involved, and the evolving trends provides a clear picture of the market's promising future.
Forecasted Market Size and Growth Outlook for the Fentanyl Market
The fentanyl market is projected to expand significantly, reaching a value of $22.03 billion…
Global Fentanyl Market Overview 2033 : Forecasted Market Size And Growth Rate
"The Business Research Company recently released a comprehensive report on the Global Fentanyl Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The fentanyl market size has grown…
Fentanyl Market to Signify Strong Growth by 2023-2029
Fentanyl Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.52% from 2024 to 2030. As the demand for effective pain relief solutions continues to rise, the Fentanyl market presents a dynamic landscape, characterized by innovation, accessibility, and the pursuit of enhanced patient care. Let's delve into the world of Fentanyl and uncover the opportunities shaping the…
The Global Fentanyl Patch Market: Analysis of Regional Opportunities 2027
Fentanyl, also known as fentanil, is a strong opioid that is used as a pain reliever and in combination with other anesthetics.
Get Sample Pages of Report @
https://www.infinitybusinessinsights.com/request_sample.php?id=625408
The Fentanyl Patch market is one of the biggest and generally complex in the economy, representing generally total national output. The medical services area benefits from a solid arrangement of clinical innovative work, in participation with the advanced education framework and the innovation…
Final Appeal Briefing Issued in $16 Million Illinois Fentanyl Patch Lawsuit
CHICAGO – The First District of the Illinois Court of Appeals has received final briefing in the appeal of a $16.56 million judgment entered more than two years ago against Johnson & Johnson (NYSE: JNJ) subsidiaries Janssen Pharmaceutica Inc. and ALZA Corp.
The appeal stems from a Nov. 17, 2008, jury verdict in Judge Thomas Flanagan's Cook County Circuit Court. Jurors found Janssen and ALZA liable in the death of…
Jury Awards $16.5 Million in Fentanyl Death Case
DiCosolo family lawyer Jim Orr says Duragesic patch was known to have problems
CHICAGO – A jury in Chicago has found two Johnson & Johnson subsidiaries liable in the death of a Cicero, Ill., woman who died while using a Duragesic® patch, and ordered the companies to pay her family $16,560,000.
The verdict in the case involving 38-year-old Janice DiCosolo, a mother of three, was delivered in Judge Thomas Flanagan’s courtroom…
